Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics granted inducement RSUs covering an aggregate 56,220 shares of common stock to 16 new employees on September 10, 2026, under Nasdaq Listing Rule 5635(c)(4). The grants were made outside the 2018 Equity Incentive Plan as material inducements to employment and vest over four years, with 25% of the shares vesting on each grant-date anniversary, subject to continued service.
Key figures
- Grant date
- 2026-09-10
- Vesting schedule
- four years, 25% of shares vest on each anniversary of the grant date
- Employees granted
- 16
- Inducement rsu shares
- 56220
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.